This compound is a pharmaceutical intermediate used in the manufacturing of abiraterone-related substances. It features a complex polycyclic structure with multiple ester and ether groups, primarily serving as a synthetic building block in laboratory and research settings.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 186826-68-6
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Acétate d'abiratérone
active pharmaceutical ingredient
(3?)-16-[(3?)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone dimer impurity
Ambroxol EP Impurity B
Pharmaceutical intermediate for ambroxol
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
pharmaceutical intermediate
2-(2-cyanophenyl)acetic acid
Pharmaceutical intermediate
2-Methyl-3-nitropyridine
pharmaceutical intermediate
[(3S,8R,9S,10R,13S,14S)-17-[(3S,8R,9S,10R,13S,14S)-3-acetyloxy-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-16-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
LFPGBQAWACWPBR-NBDAZIKLSA-N
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=C([C@]6(CC[C@H]7[C@H]([C@@H]6C5)CC=C8[C@@]7(CC[C@@H](C8)OC(=O)C)C)C)C9=CN=CC=C9)C)C
—